Acquisition of large patent portfolios not anticompetitive, says US DOJ
MLex Summary: The US Department of Justice filed a brief urging an appeals court to exclude AbbVie’s patent procurement from its alleged anticompetitive conduct when assessing the adequacy of antitrust claims...To view the full article, register now.
Already a subscriber? Click here to view full article